9,904
Total Claims
$734K
Drug Cost
893
Beneficiaries
$822
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-42%
Cost per patient vs peers
$822 vs $1,411 avg
-13%
Brand preference vs peers
9.2% vs 10.6% avg
Brand vs Generic
91% generic
Brand: 910 claims · $548K
Generic: 8,962 claims · $186K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Rivaroxaban | 73 | $86K |
| Apixaban | 55 | $80K |
| Dapagliflozin Propanediol | 28 | $37K |
| Empagliflozin | 23 | $33K |
| Sitagliptin Phosphate | 22 | $27K |
| Umeclidinium Brm/Vilanterol Tr | 17 | $25K |
| Semaglutide | 20 | $22K |
| Esomeprazole Magnesium | 11 | $16K |
| Fluticasone/Umeclidin/Vilanter | 20 | $16K |
| Dulaglutide | 12 | $12K |
| Atorvastatin Calcium | 929 | $11K |
| Fluticasone/Vilanterol | 15 | $9,370 |
| Tamsulosin Hcl | 374 | $7,010 |
| Levothyroxine Sodium | 466 | $6,964 |
| Fluticasone Propion/Salmeterol | 11 | $5,436 |
Prescribing Profile
Patient Profile
77
Avg Age
30%
Female
1.17
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data